The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary

Marko M. Altaras, Gary L. Goldberg, Wilfred Levin, Lynne Darge, Basil Bloch, James A. Smith

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

The value of cancer antigen-125 (CA-125) as a tumor marker for malignant germ cell tumors (MGCT) of the ovary was investigated and compared with the other recognized tumor markers (human chorionic gonadotrophin (hCG), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA)) and lactate dehydrogenase (LDH) isoenzymes. In the 10 months following June 1984, 4 new cases with MGCT and 1 patient with active disease on treatment were evaluated. In all cases prior to planned surgery the levels of CA-125 were significantly elevated. The serum values ranged from 154 to 617 U/ml (normal < 20 U/ml). In 1 case (pure dysgerminoma) CA-125 was the only tumor marker. In 3 patients (2 mixed germ cell tumors and 1 immature teratoma) serum LDH (LD 1, 2, and 3) was elevated, and AFP was elevated in 1 of these. In the fifth case (mixed germ cell tumor), on treatment, serum AFP was used to monitor the disease. Four patients underwent cytoreductive surgery followed by combination chemotherapy. The changes in the serum levels of CA-125 paralleled those of the other tumor markers while on therapy. In our experience CA-125 is an invaluable indicator of the clinical status of the patient and could be a new tumor marker in patients with MGCT.

Original languageEnglish (US)
Pages (from-to)150-159
Number of pages10
JournalGynecologic Oncology
Volume25
Issue number2
DOIs
StatePublished - Oct 1986

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary'. Together they form a unique fingerprint.

  • Cite this

    Altaras, M. M., Goldberg, G. L., Levin, W., Darge, L., Bloch, B., & Smith, J. A. (1986). The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary. Gynecologic Oncology, 25(2), 150-159. https://doi.org/10.1016/0090-8258(86)90096-X